CSL R&D is driving significant transformation — accelerating its data and AI ambitions in a way that demands architecture thinking rooted in business value, not just technical delivery. The R&D Data Architect is a brand new
Manager, Quality Systems - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in